Computational screening implemented in Japan

Genedata’s system for high throughput screening of data is being used at Japanese pharmaceutical company Chugai to discover drugs for cancer and bone and joint diseases.

Genedata Screener has been used over the past 12 months at Chugai, providing assay optimisation and validation screening. It has provided more robust measures for the biological effects of drugs. It also provides data quality assurance, and automates the analysis process.

The collaboration began with a case study performed on data from Chugai’s research facilities near Tokyo, demonstrating the speed and efficiency of Genedata’s computational approach.

'Data visualisation and data quality assurance were key drivers behind choosing Genedata’s solution,' explained Hiroki Takaya, group manager of the pharmaceutical technology department, Chugai Pharmaceutical.

This is Genedata's first Japanese project, and represents a conscious effort to increase its global position in the market.

Twitter icon
Google icon icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon

For functionality and security for externalised research, software providers have turned to the cloud, writes Sophia Ktori


Robert Roe looks at the latest simulation techniques used in the design of industrial and commercial vehicles


Robert Roe investigates the growth in cloud technology which is being driven by scientific, engineering and HPC workflows through application specific hardware


Robert Roe learns that the NASA advanced supercomputing division (NAS) is optimising energy efficiency and water usage to maximise the facility’s potential to deliver computing services to its user community


Robert Roe investigates the use of technologies in HPC that could help shape the design of future supercomputers